MediPharm Labs Corp.

Supplying Canada with Pharma-Grade Cannabis

Overview

MediPharm Labs Corp. (TSX:LABS, OTCQX:MEDIF, FSE:MLZ) is a leading B2B specialized Canadian cannabis extractor, producing purified pharma-grade cannabis oil and concentrates for the development of cannabinoid derived products. As part of their B2B model, MediPharm Labs supplies raw materials, formulations, processing and packaging for ready-to-sell advanced derivative products.

The first Canadian company to become a licensed producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without being a licensed cultivator, MediPharm Labs is focused on bringing pharma-grade products to the adult-use and medical cannabis industries in Canada. The company expects to receive its license to extract and import medical cannabis products in Australia and to have its facility operational in Australia in the near term(Q2 2019).

Company Highlights

  • Primarily focused on producing pharma-grade cannabis oil and concentrates.
  • Named Cannabis Start-Up of the Year at the 2018 Canadian Cannabis Awards by LIFT&Co.
  • Wholly-owned 70,000-square-foot facility has been constructed to EU GMP standards with ISO rated clean rooms, and is operational.
  • Pharma-grade critical environments, methodologies and discipline result in repeatability in manufacturing